News & Insights

Praedicat in the news.

Read what we think and what others think, all meant to make you think.

Filter posts by:

Carrier Management – The Risk of ‘Take Home’ COVID-19 & the ‘Next Asbestos’
Carrier Management – The Risk of ‘Take Home’ COVID-19 & the ‘Next Asbestos’ 750 350 Meghan Dengler

July 6th, 2020: In the Carrier Management article, The Risk of ‘Take-Home’ COVID-19 and the Next Asbestos, our SVP of Modeling, Melissa Boudreau and CEO Robert Reville discuss Praedicat’s latest…

read more

Praedicat Launches COVID-19 Litigation Tracker
Praedicat Launches COVID-19 Litigation Tracker 1280 450 Meghan Dengler

June 25th, 2020: Praedicat announces the launch of our unprecedented COVID-19 Litigation Tracker Praedicat is proud to introduce our new Litigation Tracker, which monitors emerging SARS-CoV-2 litigation complaint by complaint.…

read more

Coffee with Bob: The Pandemic Behind the Pandemic
Coffee with Bob: The Pandemic Behind the Pandemic 1200 462 Bob Reville

Coffee with Bob featuring Dr. Robert Lustig Coffee with Bob: The Pandemic Behind the Pandemic On Tuesday, June 23, 2020 Praedicat hosted a new episode in its webinar series: Coffee…

read more

Praedicat Press Release – COVID-19 Scenarios
Praedicat Press Release – COVID-19 Scenarios 750 350 Meghan Dengler

June 8th, 2020: Praedicat announces the launch of a scenario-based COVID-19 exposure modeling program. . Praedicat has developed scenarios that represent a range of ultimate pandemic outcomes, including fully-specified causes…

read more

Praedicat’s Latest Product Update- ChemMeta Notifications
Praedicat’s Latest Product Update- ChemMeta Notifications 750 350 Meghan Dengler

June 2nd 2020: Introducing ChemMeta notifications! . The Latest Science In Your Inbox . Praedicat is pleased to announce the newest enhancement in ChemMeta. This latest update features the highly anticipated…

read more

Praedicat Launches COVID-19 Scenarios
Praedicat Launches COVID-19 Scenarios 750 350 Meghan Dengler

Praedicat announces the launch of COVID-19 litigation scenarios Millions worldwide have been infected with the novel coronavirus SARS-CoV-2 and sickened by the respiratory illness COVID-19. The epidemiological and economic course…

read more

Coffee with Bob: Scenarios for Large-Scale COVID-19 Litigation
Coffee with Bob: Scenarios for Large-Scale COVID-19 Litigation 1200 462 Bob Reville

Coffee with Bob: Scenarios for Large-Scale COVID-19 Litigation On Thursday May 14, 2020 Praedicat hosted the first session of its free webinar series: Coffee with Bob. In the inaugural episode,…

read more

Oxbow Partners Bitesize Interview
Oxbow Partners Bitesize Interview 750 350 Meghan Dengler

May 9th 2020: In the Bitesize article, Oxbow Partners gives a first glimpse of Praedicat’s COVID-19 scenario modelling solution and litigation tracker, both of which are set to launch later…

read more

Insurance ERM: Praedicat Scenario Tool Targets COVID-19 Litigation Assessments
Insurance ERM: Praedicat Scenario Tool Targets COVID-19 Litigation Assessments 750 350 Meghan Dengler

April 29th: In an article published by Insurance ERM, Praedicat scenario tool targets Covid-19 litigation assessments, Robert Reville, Praedicat CEO, discusses the upcoming launch of a suite of tools to…

read more

Carrier Management – 5G Wireless Technologies: Suspicion vs. Evidence
Carrier Management – 5G Wireless Technologies: Suspicion vs. Evidence 750 350 Meghan Dengler

April 27th, 2020: One of the more surprising recent conspiracy theories to make the rounds of the Internet and social media is that the COVID-19 pandemic is actually a hoax…

read more

Plotting the Future of the Underwriter
Plotting the Future of the Underwriter 3554 1652 Meghan Dengler

April 21st 2020: Become the Underwriter of the Future Jessica Schuler, VP, Strategic Initiatives at Praedicat joined a panel of industry experts during a Praedicat sponsored webinar, “Become the Underwriter…

read more

Stay In Touch
Stay In Touch 3554 1660 Meghan Dengler

Sign up to receive the latest news, insights and information from Praedicat. Name* First Last TitleCompany Name*Email* Consent* I agree to receive email updates from Praedicat.Questions and/or Comments

read more
Start Typing